Full-Time

QAD Developer

Posted on 8/22/2024

PROCEPT BioRobotics

PROCEPT BioRobotics

501-1,000 employees

Develops robotic solutions for BPH treatment

Robotics & Automation
Healthcare

Compensation Overview

$120k - $150kAnnually

+ Bonus + Equity/RSUs

Mid, Senior

No H1B Sponsorship

San Jose, CA, USA

This role is hybrid, offering flexibility to work partially from home while collaborating with teams across the organization.

Category
Backend Engineering
Software QA & Testing
Software Engineering
Required Skills
Inventory Management
SQL
Linux/Unix
Requirements
  • Bachelor’s degree in Computer Science or a related field.
  • 5+ years of relevant IT and/or business experience in the medical device, biotech, pharmaceutical, healthcare industry, or related consulting services.
  • Expertise in Progress ERP programming.
  • Experience with QAD .Net UI and Unix/Linux operating systems.
  • Experience with manufacturing modules (e.g., Forecast, MRP, Inventory Management, Production Orders, Quality Management).
  • Strong analytical and quantitative skills, with proficiency in SQL
Responsibilities
  • Collaborate with key stakeholders to translate business requirements into technical solutions.
  • Design, develop, implement, and maintain Progress 4GL/OpenEdge applications and code within the QAD application.
  • Provide ongoing technical support and troubleshooting for various business functions and processes.
  • Proactively communicate with stakeholders to identify and implement process improvements.
  • Prioritize and deliver on IT requests in collaboration with departments across the organization.
  • Ensure compliance with the PROCEPT BioRobotics Quality Management System and regulatory requirements.

PROCEPT BioRobotics develops robotic solutions specifically for treating benign prostatic hyperplasia (BPH), a condition that affects many older men by causing prostate enlargement and urinary issues. Their main product, the AquaBeam Robotic System, utilizes Aquablation therapy, which combines real-time imaging, robotics, and waterjet technology to precisely remove prostate tissue in a minimally invasive manner. This system is designed for urologists and healthcare facilities, focusing on enhancing patient outcomes and making surgical procedures more efficient. Unlike competitors, PROCEPT BioRobotics emphasizes predictable results and reduced complications, which has led to their technology being recognized in clinical guidelines. The company's goal is to improve the quality of life for patients suffering from BPH through advanced surgical solutions.

Company Stage

IPO

Total Funding

$319.1M

Headquarters

Redwood City, California

Founded

2009

Growth & Insights
Headcount

6 month growth

0%

1 year growth

1%

2 year growth

2%
Simplify Jobs

Simplify's Take

What believers are saying

  • Increasing adoption of robotic-assisted surgeries boosts demand for AquaBeam System.
  • Global urology devices market projected to grow at 6.9% CAGR until 2030.
  • FDA's supportive regulatory environment favors innovative medical technologies like PROCEPT's.

What critics are saying

  • Competition from Intuitive Surgical and Medtronic may impact market share.
  • $175 million public stock offering could lead to shareholder dilution.
  • Reliance on AquaBeam System makes company vulnerable to technological failures.

What makes PROCEPT BioRobotics unique

  • AquaBeam Robotic System offers image-guided, minimally invasive urologic surgery.
  • Aquablation therapy provides effective outcomes regardless of prostate size or surgeon experience.
  • PROCEPT has over 100 peer-reviewed publications supporting Aquablation therapy's benefits.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

401(k) Company Match

401(k) Retirement Plan

Paid Vacation

Paid Parental Leave

Paid Holidays

Wellness Program

Gym Membership

INACTIVE